Alkermes (ALKS) Gross Profit (2010 - 2026)
Alkermes (ALKS) reported Gross Profit of -$116.1 million for Q1 2026, down 163.22% year-over-year from $183.6 million in Q1 2025, and down 143.92% quarter-over-quarter from $264.3 million in Q4 2025.
Alkermes (ALKS) Gross Profit (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Gross Profit data on file, last reported at -$116.1 million in Q1 2026.
- Gross Profit for Q1 2026 came in at -$116.1 million, down 163.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $768.0 million (down 34.09% YoY), and the FY2025 annual result was $995.9 million, down 24.11% from the prior year.
- Gross Profit slipped to -$116.1 million in Q1 2026 per ALKS's latest filing, from $264.3 million in the prior quarter.
- Over five years, Gross Profit peaked at $554.1 million in Q2 2023 and troughed at -$116.1 million in Q1 2026.
- A 5-year average of $231.8 million and a median of $264.3 million in 2025 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2023 and 2026: Gross Profit soared 1104.62% in 2023, then tumbled 163.22% in 2026.
- A 5-year view of Gross Profit shows it stood at $250.8 million in 2022, then gained by 22.57% to $307.3 million in 2023, then increased by 19.69% to $367.9 million in 2024, then fell by 28.16% to $264.3 million in 2025, then slumped by 143.92% to -$116.1 million in 2026.
- Business Quant data shows ALKS's Gross Profit at -$116.1 million in Q1 2026, $264.3 million in Q4 2025, and $278.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.06 Mn |
| Mar 31, 2026 | -116.06 Mn |
| Dec 31, 2025 | 264.28 Mn |
| Dec 31, 2025 | 264.28 Mn |
| Sep 30, 2025 | 278.56 Mn |
| Sep 30, 2025 | 278.56 Mn |
| Jun 30, 2025 | 341.20 Mn |
| Jun 30, 2025 | 341.20 Mn |
| Mar 31, 2025 | 183.58 Mn |
| Mar 31, 2025 | 183.58 Mn |
| Dec 31, 2024 | 367.87 Mn |
| Dec 31, 2024 | 367.87 Mn |
| Sep 30, 2024 | 276.10 Mn |
| Sep 30, 2024 | 276.10 Mn |
| Jun 30, 2024 | 337.66 Mn |
| Jun 30, 2024 | 337.66 Mn |
| Mar 31, 2024 | 224.76 Mn |
| Mar 31, 2024 | 224.76 Mn |
| Dec 31, 2023 | 307.35 Mn |
| Dec 31, 2023 | 307.35 Mn |